ZA993853B - Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole]. - Google Patents

Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].

Info

Publication number
ZA993853B
ZA993853B ZA9903853A ZA993853A ZA993853B ZA 993853 B ZA993853 B ZA 993853B ZA 9903853 A ZA9903853 A ZA 9903853A ZA 993853 A ZA993853 A ZA 993853A ZA 993853 B ZA993853 B ZA 993853B
Authority
ZA
South Africa
Prior art keywords
pyrolo
spiro
pyrrole
piperidine
Prior art date
Application number
ZA9903853A
Other languages
English (en)
Inventor
Geo Adam
Frank Dautzenberg
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA993853B publication Critical patent/ZA993853B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Photoreceptors In Electrophotography (AREA)
ZA9903853A 1998-06-12 1999-06-08 Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole]. ZA993853B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12

Publications (1)

Publication Number Publication Date
ZA993853B true ZA993853B (en) 1999-12-13

Family

ID=8232113

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9903853A ZA993853B (en) 1998-06-12 1999-06-08 Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
ZA9903901A ZA993901B (en) 1998-06-12 1999-06-10 Di-or triaza-spiro(4,5)decane derivates.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA9903901A ZA993901B (en) 1998-06-12 1999-06-10 Di-or triaza-spiro(4,5)decane derivates.

Country Status (30)

Country Link
US (1) US6642247B2 (sh)
EP (1) EP0963985B1 (sh)
JP (1) JP3369123B2 (sh)
KR (1) KR100393311B1 (sh)
CN (2) CN1110497C (sh)
AR (1) AR019860A1 (sh)
AT (1) ATE234302T1 (sh)
AU (1) AU752835B2 (sh)
BR (1) BR9902653A (sh)
CA (1) CA2274201C (sh)
CO (1) CO5040061A1 (sh)
CZ (1) CZ291323B6 (sh)
DE (1) DE69905798T2 (sh)
DK (1) DK0963985T3 (sh)
ES (1) ES2194402T3 (sh)
HR (1) HRP990187A2 (sh)
HU (1) HUP9901910A3 (sh)
ID (1) ID23306A (sh)
IL (1) IL130375A0 (sh)
MA (1) MA26645A1 (sh)
NO (1) NO312591B1 (sh)
NZ (1) NZ336226A (sh)
PE (1) PE20000540A1 (sh)
PL (1) PL333693A1 (sh)
PT (1) PT963985E (sh)
SG (1) SG83135A1 (sh)
TR (1) TR199901380A3 (sh)
TW (1) TW434241B (sh)
YU (1) YU26799A (sh)
ZA (2) ZA993853B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237047T3 (es) * 1998-10-23 2005-07-16 Pfizer Inc. Compuestos de 1,3,8-triazaespiro(4,5)decanona como agonistas del receptor orl1.
DK1491212T3 (da) 2002-03-29 2012-10-29 Mitsubishi Tanabe Pharma Corp Middel til behandling af søvnforstyrrelser
DE102004014296A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen
KR100662191B1 (ko) 2004-12-23 2006-12-27 엘지이노텍 주식회사 질화물 반도체 발광소자 및 그 제조방법
EP2128154B1 (en) 2007-03-01 2015-04-08 Mitsubishi Tanabe Pharma Corporation Benzimidazole compound and pharmaceutical use thereof
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
CN109503582A (zh) * 2018-12-17 2019-03-22 上海合全药物研发有限公司 顺式螺[哌啶并-4,1＇-吡咯并[3,4-c]吡咯]-1-甲酸叔丁酯的合成方法
CN113966337B (zh) * 2020-05-12 2024-01-02 北京广为医药科技有限公司 调节nmda受体活性的化合物、其药物组合物及用途
KR20220022988A (ko) 2020-08-20 2022-03-02 제트스타 주식회사 트랙터용 써레

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208844A (ja) * 1987-02-26 1988-08-30 Konica Corp 有機着色物質の光褪色防止方法
US5221675A (en) * 1989-12-15 1993-06-22 Abbott Laboratories Aza-spirocyclic compounds that enhance cholinergic neurotransmission
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
EP0963985A2 (en) 1999-12-15
BR9902653A (pt) 2000-05-02
US20030176701A1 (en) 2003-09-18
HU9901910D0 (en) 1999-08-30
ES2194402T3 (es) 2003-11-16
DK0963985T3 (da) 2003-06-23
JP3369123B2 (ja) 2003-01-20
CN1244528A (zh) 2000-02-16
MA26645A1 (fr) 2004-12-20
PL333693A1 (en) 1999-12-20
EP0963985B1 (en) 2003-03-12
ATE234302T1 (de) 2003-03-15
AU3498699A (en) 1999-12-23
ID23306A (id) 2000-04-05
DE69905798T2 (de) 2004-02-12
HRP990187A2 (en) 2000-02-29
NO992876D0 (no) 1999-06-11
KR20000006135A (ko) 2000-01-25
CA2274201A1 (en) 1999-12-12
CZ291323B6 (cs) 2003-02-12
CA2274201C (en) 2010-02-09
PE20000540A1 (es) 2000-07-15
CZ203999A3 (cs) 2000-03-15
HUP9901910A3 (en) 2001-11-28
CN1229377C (zh) 2005-11-30
ZA993901B (en) 1999-12-13
CO5040061A1 (es) 2001-05-29
IL130375A0 (en) 2000-06-01
EP0963985A3 (en) 2001-01-24
HUP9901910A2 (hu) 2000-04-28
YU26799A (sh) 2002-03-18
CN1242367A (zh) 2000-01-26
AR019860A1 (es) 2002-03-20
NO992876L (no) 1999-12-13
NZ336226A (en) 2000-10-27
NO312591B1 (no) 2002-06-03
AU752835B2 (en) 2002-10-03
PT963985E (pt) 2003-06-30
KR100393311B1 (ko) 2003-08-02
TW434241B (en) 2001-05-16
CN1110497C (zh) 2003-06-04
DE69905798D1 (de) 2003-04-17
SG83135A1 (en) 2001-09-18
TR199901380A2 (xx) 2001-01-22
JP2000026466A (ja) 2000-01-25
TR199901380A3 (tr) 2001-01-22
US6642247B2 (en) 2003-11-04

Similar Documents

Publication Publication Date Title
EP0648770A3 (de) Neue Pyrrolo 3,4-c pyrrole.
ZA979516B (en) Thienopyrimidines.
ZA977156B (en) Thienopyrimidines.
AP9901583A0 (en) Pyrrolo[2,3-d] pirimidine compounds
GR3036523T3 (en) 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives
HU9501600D0 (en) Thieno[1,5]benzodiazepine use
AU5516399A (en) Dihydro-(1,2,3)triazolo-(4,5-d)pyrimidin-7-one
ZA975616B (en) Colored composition.
ZA976492B (en) Substituted pyrroles.
SG79259A1 (en) Diaza-spiro[3,5]nonane deravatives
ZA992072B (en) Substituted pyrroles.
SG54341A1 (en) Tricyclic 5,6-dihydro-9h-pyrazola[3,4-c] 1,2,4-triazolo[4,3-alpha] pyridines
ZA972829B (en) Novel pyrimido [1,2-a]indoles.
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
IL135982A0 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
SG76623A1 (en) Spiro [piperidine-4, 1'-pyrrolo[3,4-c]pyrrole]
ZA976487B (en) Substituted pyrroles.
ZA974538B (en) Novel pyrrole derivatives.
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
ZA972984B (en) Spiro[cyclopent[b]indole-piperidines.
IL149051A0 (en) Pyrazolo [1,5,-d] [1,2,4] triazines for enhancing cognition
ZA966940B (en) Locking means.
ZA964649B (en) Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines.
AU8760498A (en) Taper lock arrangement
ZA976488B (en) Substituted pyrroles.